Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer

Efficacy of chemotherapy for pancreatic cancer may be improved by tailoring it to individual chemosensitivity profiles. Identification of nonresponders before initiation of treatment may help to avoid side effects. In this study, primary pancreatic cancer cells were isolated from 18 patients undergo...

Descripción completa

Detalles Bibliográficos
Autores principales: Michalski, C W, Erkan, M, Sauliunaite, D, Giese, T, Stratmann, R, Sartori, C, Giese, N A, Friess, H, Kleeff, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528151/
https://www.ncbi.nlm.nih.gov/pubmed/18728667
http://dx.doi.org/10.1038/sj.bjc.6604528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528151/
https://www.ncbi.nlm.nih.gov/pubmed/18728667
http://dx.doi.org/10.1038/sj.bjc.6604528

Ejemplares similares